1. Toole BP. Hyaluronan: from extracellular glue to pericellular cue. Nat Rev Cancer. 2004; 4(7):528–39. Epub 2004/07/02. doi: 10.1038/nrc1391. PMID: 15229478.
2. Misra S, Hascall VC, Markwald RR, Ghatak S. Interactions between Hyaluronan and Its Receptors (CD44, RHAMM) Regulate the Activities of Inflammation and Cancer. Front Immunol. 2015; 6:201. Epub 2015/05/23. doi: 10.3389/fimmu.2015.00201. PMID: 25999946; PubMed Central PMCID: PMC4422082.
3. Onodera Y, Teramura T, Takehara T, Fukuda K. Hyaluronic acid regulates a key redox control factor Nrf2 via phosphorylation of Akt in bovine articular chondrocytes. FEBS Open Bio. 2015; 5:476–84. Epub 2015/06/25. doi: 10.1016/j.fob.2015.05.007. PMID: 26106522; PubMed Central PMCID: PMC4475775.
4. Jiao Q, Wei L, Chen C, Li P, Wang X, Li Y, et al. Cartilage oligomeric matrix protein and hyaluronic acid are sensitive serum biomarkers for early cartilage lesions in the knee joint. Biomarkers. 2015:1–6. Epub 2015/12/05. doi: 10.3109/1354750x.2015.1118547. PMID: 26634947.
5. Chan DD, Xiao WF, Li J, de la Motte CA, Sandy JD, Plaas A. Deficiency of hyaluronan synthase 1 (Has1) results in chronic joint inflammation and widespread intra-articular fibrosis in a murine model of knee joint cartilage damage. Osteoarthritis Cartilage. 2015; 23(11):1879–89. Epub 2015/11/03. doi: 10. 1016/j.joca.2015.06.021. PMID: 26521733; PubMed Central PMCID: PMC4630789.
6. Mongkhon JM, Thach M, Shi Q, Fernandes JC, Fahmi H, Benderdour M. Sorbitol-modified hyaluronic acid reduces oxidative stress, apoptosis and mediators of inflammation and catabolism in human oste- oarthritic chondrocytes. Inflamm Res. 2014; 63(8):691–701. Epub 2014/05/27. doi: 10.1007/s00011- 014-0742-4. PMID: 24858301.
7. Fukui T, Kitamura N, Kurokawa T, Yokota M, Kondo E, Gong JP, et al. Intra-articular administration of hyaluronic acid increases the volume of the hyaline cartilage regenerated in a large osteochondral defect by implantation of a double-network gel. J Mater Sci Mater Med. 2014; 25(4):1173–82. Epub 2014/01/08. doi: 10.1007/s10856-013-5139-3. PMID: 24394983.
8. Hiramitsu T, Yasuda T, Ito H, Shimizu M, Julovi SM, Kakinuma T, et al. Intercellular adhesion molecule- 1 mediates the inhibitory effects of hyaluronan on interleukin-1beta-induced matrix metalloproteinase production in rheumatoid synovial fibroblasts via down-regulation of NF-kappaB and p38. Rheumatol- ogy (Oxford). 2006; 45(7):824–32. Epub 2006/02/02. doi: 10.1093/rheumatology/kel026. PMID: 16449361.
9. Lisignoli G, Grassi F, Zini N, Toneguzzi S, Piacentini A, Guidolin D, et al. Anti-Fas-induced apoptosis in chondrocytes reduced by hyaluronan: evidence for CD44 and CD54 (intercellular adhesion molecule 1) invovement. Arthritis and rheumatism. 2001; 44(8):1800–7. Epub 2001/08/18. doi: 10.1002/1529-0131 (200108)44:8<1800::AID-ART317>3.0.CO;2-1. PMID: 11508432.
10. McCourt PA, Ek B, Forsberg N, Gustafson S. Intercellular adhesion molecule-1 is a cell surface receptor for hyaluronan. J Biol Chem. 1994; 269(48):30081–4. Epub 1994/12/02. PMID: 7527024.
11. Lu X, Huang X. Design and syntheses of hyaluronan oligosaccharide conjugates as inhibitors of CD44- Hyaluronan binding. Glycoconj J. 2015; 32(7):549–56. Epub 2015/05/23. doi: 10.1007/s10719-015- 9597-3. PMID: 25997408.
12. Lo WC, Chen WH, Lin TC, Hwang SM, Zeng R, Hsu WC, et al. Preferential therapy for osteoarthritis by cord blood MSCs through regulation of chondrogenic cytokines. Biomaterials. 2013; 34(20):4739–48. Epub 2013/04/06. doi: 10.1016/j.biomaterials.2013.03.016. PMID: 23557858.
13. Davies ME, Dingle JT, Pigott R, Power C, Sharma H. Expression of intercellular adhesion molecule 1 (ICAM-1) on human articular cartilage chondrocytes. Connect Tissue Res. 1991; 26(3):207–16. Epub 1991/01/01. doi: 10.3109/03008209109152439. PMID: 1722744.
14. Yasuda T. Hyaluronan inhibits p38 mitogen-activated protein kinase via the receptors in rheumatoid arthritis chondrocytes stimulated with fibronectin fragment. Clin Rheumatol. 2010; 29(11):1259–67. Epub 2010/06/17. doi: 10.1007/s10067-010-1512-5. PMID: 20552237.
15. Yasuda T. Hyaluronan inhibits cytokine production by lipopolysaccharide-stimulated U937 macro- phages through down-regulation of NF-kappaB via ICAM-1. Inflamm Res. 2007; 56(6):246–53. Epub 2007/07/04. doi: 10.1007/s00011-007-6168-5. PMID: 17607549.
16. Yatabe T, Mochizuki S, Takizawa M, Chijiiwa M, Okada A, Kimura T, et al. Hyaluronan inhibits expres- sion of ADAMTS4 (aggrecanase-1) in human osteoarthritic chondrocytes. Ann Rheum Dis. 2009; 68 (6):1051–8. Epub 2008/07/30. doi: 10.1136/ard.2007.086884. PMID: 18662930; PubMed Central PMCID: PMC2674548.
17. Zhang LP, Kline RHt, Deevska G, Ma F, Nikolova-Karakashian M, Westlund KN. Alcohol and high fat induced chronic pancreatitis: TRPV4 antagonist reduces hypersensitivity. Neuroscience. 2015; 311:166–79. Epub 2015/10/21. doi: 10.1016/j.neuroscience.2015.10.028. PMID: 26480812; PubMed Central PMCID: PMC4670827.
18. Adapala RK, Thoppil RJ, Ghosh K, Cappelli HC, Dudley AC, Paruchuri S, et al. Activation of mechano- sensitive ion channel TRPV4 normalizes tumor vasculature and improves cancer therapy. Oncogene. 2015. Epub 2015/04/14. doi: 10.1038/onc.2015.83. PMID: 25867067.
19. Scheraga RG, Abraham S, Niese KA, Southern BD, Grove LM, Hite RD, et al. TRPV4 Mechanosensi- tive Ion Channel Regulates Lipopolysaccharide-Stimulated Macrophage Phagocytosis. J Immunol. 2015. Epub 2015/11/26. doi: 10.4049/jimmunol.1501688. PMID: 26597012.
20. Guilak F, Leddy HA, Liedtke W. Transient receptor potential vanilloid 4: The sixth sense of the musculo- skeletal system? Ann N Y Acad Sci. 2010; 1192:404–9. Epub 2010/04/16. doi: 10.1111/j.1749-6632. 2010.05389.x. PMID: 20392266; PubMed Central PMCID: PMC3580043.
21. O’Conor CJ, Leddy HA, Benefield HC, Liedtke WB, Guilak F. TRPV4-mediated mechanotransduction regulates the metabolic response of chondrocytes to dynamic loading. Proc Natl Acad Sci U S A. 2014; 111(4):1316–21. Epub 2014/01/30. doi: 10.1073/pnas.1319569111. PMID: 24474754; PubMed Central PMCID: PMC3910592.
22. Lev R, Spicer SS. Specific Staining of Sulphate Groups with Alcian Blue at Low Ph. J Histochem Cyto- chem. 1964; 12:309. doi: 10.1177/12.4.309. PMID: 14187344.
23. Watanabe H, Davis JB, Smart D, Jerman JC, Smith GD, Hayes P, et al. Activation of TRPV4 channels (hVRL-2/mTRP12) by phorbol derivatives. J Biol Chem. 2002; 277(16):13569–77. doi: 10.1074/jbc. M200062200. PMID: 11827975.
24. Muramatsu S, Wakabayashi M, Ohno T, Amano K, Ooishi R, Sugahara T, et al. Functional gene screening system identified TRPV4 as a regulator of chondrogenic differentiation. J Biol Chem. 2007; 282(44):32158–67. Epub 2007/09/07. doi: 10.1074/jbc.M706158200. PMID: 17804410.
25. Sato E, Ando T, Ichikawa J, Okita G, Sato N, Wako M, et al. High molecular weight hyaluronic acid increases the differentiation potential of the murine chondrocytic ATDC5 cell line. J Orthop Res. 2014; 32(12):1619–27. Epub 2014/09/10. doi: 10.1002/jor.22691. PMID: 25196420.
26. Takahashi N, Fujibayashi T, Kida D, Hirano Y, Kato T, Kato D, et al. Concomitant methotrexate and tacrolimus augment the clinical response to abatacept in patients with rheumatoid arthritis with a prior history of biological DMARD use. Rheumatol Int. 2015; 35(10):1707–16. doi: 10.1007/s00296-015- 3283-4. PMID: 25991396.
27. Sanchez JC, Lopez-Zapata DF, Wilkins RJ. TRPV4 channels activity in bovine articular chondrocytes: regulation by obesity-associated mediators. Cell Calcium. 2014; 56(6):493–503. Epub 2014/12/03. doi: 10.1016/j.ceca.2014.10.006. PMID: 25459300.
28. Phan MN, Leddy HA, Votta BJ, Kumar S, Levy DS, Lipshutz DB, et al. Functional characterization of TRPV4 as an osmotically sensitive ion channel in porcine articular chondrocytes. Arthritis and rheuma- tism. 2009; 60(10):3028–37. Epub 2009/10/01. doi: 10.1002/art.24799. PMID: 19790068; PubMed Central PMCID: PMC2846816.
29. Addison MP, Singh TU, Parida S, Choudhury S, Kasa JK, Sukumaran SV, et al. NO synthase inhibition attenuates EDHF-mediated relaxation induced by TRPV4 channel agonist GSK1016790A in the rat pul- monary artery: Role of TxA2. Pharmacol Rep. 2016; 68(3):620–6. Epub 2016/03/19. doi: 10.1016/j. pharep.2016.01.003. PMID: 26991376.
30. Jin M, Wu Z, Chen L, Jaimes J, Collins D, Walters ET, et al. Determinants of TRPV4 activity following selective activation by small molecule agonist GSK1016790A. PloS one. 2011; 6(2):e16713. Epub 2011/02/23. doi: 10.1371/journal.pone.0016713. PMID: 21339821; PubMed Central PMCID: PMC3038856.
31. Caron MM, Emans PJ, Surtel DA, Cremers A, Voncken JW, Welting TJ, et al. Activation of NF-kappaB/ p65 facilitates early chondrogenic differentiation during endochondral ossification. PloS one. 2012; 7(3): e33467. Epub 2012/03/20. doi: 10.1371/journal.pone.0033467. PMID: 22428055; PubMed Central PMCID: PMC3299787.
32. Hirabara S, Kojima T, Takahashi N, Hanabayashi M, Ishiguro N. Hyaluronan inhibits TLR-4 dependent cathepsin K and matrix metalloproteinase 1 expression in human fibroblasts. Biochem Biophys Res Commun. 2013; 430(2):519–22. Epub 2012/12/13. doi: 10.1016/j.bbrc.2012.12.003. PMID: 23232115.
33. Yasuda T. Activation of p38 mitogen-activated protein kinase is inhibited by hyaluronan via intercellular adhesion molecule-1 in articular chondrocytes stimulated with type II collagen peptide. J Pharmacol Sci. 2012; 118(1):25–32. Epub 2011/12/14. PMID: 22156363.
34. Ariyoshi W, Okinaga T, Knudson CB, Knudson W, Nishihara T. High molecular weight hyaluronic acid regulates osteoclast formation by inhibiting receptor activator of NF-kappaB ligand through Rho kinase. Osteoarthritis Cartilage. 2014; 22(1):111–20. Epub 2013/11/05. doi: 10.1016/j.joca.2013.10.013. PMID: 24185105.
35. Bourguignon LY, Wong G, Earle C, Krueger K, Spevak CC. Hyaluronan-CD44 interaction promotes c- Src-mediated twist signaling, microRNA-10b expression, and RhoA/RhoC up-regulation, leading to Rho-kinase-associated cytoskeleton activation and breast tumor cell invasion. J Biol Chem. 2010; 285 (47):36721–35. Epub 2010/09/17. doi: 10.1074/jbc.M110.162305. PMID: 20843787; PubMed Central PMCID: PMC2978601.
36. Lessey-Morillon EC, Osborne LD, Monaghan-Benson E, Guilluy C, O’Brien ET, Superfine R, et al. The RhoA guanine nucleotide exchange factor, LARG, mediates ICAM-1-dependent mechanotransduction in endothelial cells to stimulate transendothelial migration. J Immunol. 2014; 192(7):3390–8. Epub 2014/03/04. doi: 10.4049/jimmunol.1302525. PMID: 24585879; PubMed Central PMCID: PMC3991232.
37. Xu T, Wu M, Feng J, Lin X, Gu Z. RhoA/Rho kinase signaling regulates transforming growth factor- beta1-induced chondrogenesis and actin organization of synovium-derived mesenchymal stem cells through interaction with the Smad pathway. Int J Mol Med. 2012; 30(5):1119–25. Epub 2012/08/28. doi: 10.3892/ijmm.2012.1107. PMID: 22922645.